When administering dantrolene for malignant hyperthermia, which action should the nurse take?

When administering dantrolene for malignant hyperthermia, using the reconstituted medication with 60 ml of sterile water without a bacteriostatic agent is the correct action. Dantrolene is a muscle relaxant specifically used to treat malignant hyperthermia, a life-threatening condition that can occur after certain anesthetic agents are used.

Reconstituting dantrolene with the appropriate volume of sterile water is critical for effectiveness and safety. The instruction to use 60 ml ensures that the medication is adequately diluted for proper intravenous administration, facilitating rapid and effective delivery to reverse the hypermetabolic state associated with malignant hyperthermia.

It's also important to note that bacteriostatic agents are not recommended for reconstituting dantrolene due to potential instability and adverse reactions. Therefore, preparing the medication without a bacteriostatic agent aligns with safe pharmacy practices and the specific guidelines for this medication.

While the other options provide management instructions for dantrolene, they are related to other aspects of administration or storage, which are not as central to the immediate nursing action for treating malignant hyperthermia. This choice emphasizes the need for precise preparation techniques critical in emergency situations.